锚定开门红 东北制药多维攻坚夯实开局底盘

Core Viewpoint - Northeast Pharmaceutical is actively pursuing a strong start to Q1 2026 by focusing on production capacity, market expansion, and collaborative efforts across all departments to ensure high-quality operations throughout the year [1]. Group 1: Customer Audits and Production - Customer audits are crucial for product quality and management, serving as a key link to the market and stabilizing partnerships. As of January 14, Northeast Pharmaceutical successfully completed audits for 6 domestic and international clients, involving 4 production plants and 7 raw material products, all passing the reviews [2]. - The production front is identified as the core battlefield for achieving a strong start. Various production plants have mobilized to meet the surge in demand, with innovative strategies such as "modular rapid switching" and continuous operations during holidays to ensure timely delivery of customized orders [2]. Group 2: Data-Driven Sales and Cost Efficiency - The sales team is leveraging data to drive market opportunities, ensuring sufficient inventory for best-selling products and maintaining uninterrupted market supply. This proactive approach aims to expand growth potential for the strong start [3]. - Cost reduction and efficiency enhancement are vital for achieving a strong start. The production command center is implementing refined management practices, focusing on key data changes and organizing weekly meetings to analyze production cost indicators, thereby improving product competitiveness [3]. Group 3: Collaborative Innovation - Subsidiaries are actively contributing to the strong start through innovative approaches and a unified strategy. For instance, the technology service company has signed contracts with multiple clients to expand external markets, while logistics and design companies are enhancing efficiency and project delivery through innovative technologies [4]. - The overall strategy emphasizes collaboration across business lines, aiming for a coordinated effort to achieve the Q1 goals and support high-quality development throughout the year [4].